Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Fabry
Disease Information
Management of Fabry Disease
Medical Information Services
Fabry Registry
Practical Info
Request Materials
MPS I
Pompe

 



 

Fabry Disease - Angiokeratoma

Angiokeratoma are the most visibly recognizable clinical feature of Fabry disease. These dark red or purple skin lesions (ranging in size from pinpoint to several millimeters in diameter) do not blanch with pressure and are usually distributed on the buttocks, groin, umbilicus, and upper thighs (bathing trunk distribution). Lesions generally appear in adolescence or young adulthood. Angiokeratoma are almost universal in male hemizygotes; they occur in approximately 30% of heterozygous females. [1, 2]

Angiokeratoma in bathing trunk area

Because angiokeratoma may be concealed by undergarments, their presence can be missed during routine physical examinations.

References
1. Desnick RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill, 2001;3733-3774

2. Menkes DL. Images in neurology. The cutaneous stigmata of Fabry disease: an X-linked phakomatosis associated with central and peripheral nervous system dysfunction. Arch Neurol. 1999;56:487.

 
Print

PRINT

Bookmark

BOOKMARK




01/01/2007: Low bone density in Gaucher disease improves with CerezymeŽ

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with FabrazymeŽ significantly slows progression of Fabry

More >



Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease